Published in J Clin Microbiol on February 16, 2011
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev (2012) 5.65
New Delhi metallo-β-lactamase-1: local acquisition in Ontario, Canada, and challenges in detection. CMAJ (2011) 1.73
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat (2012) 1.42
New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis (2013) 1.40
The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection. J Clin Microbiol (2016) 1.26
IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J Clin Microbiol (2011) 1.19
Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis (2014) 1.18
Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-β-lactamase (blaNDM) in Gram-negative bacilli. J Clin Microbiol (2013) 1.16
Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol (2014) 1.06
First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil. Antimicrob Agents Chemother (2014) 1.03
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae. Antimicrob Agents Chemother (2013) 1.01
Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States. Pediatr Infect Dis J (2015) 0.98
Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol (2011) 0.95
Antimicrobial stewardship: attempting to preserve a strategic resource. J Community Hosp Intern Med Perspect (2011) 0.85
Enhanced killing of antibiotic-resistant bacteria enabled by massively parallel combinatorial genetics. Proc Natl Acad Sci U S A (2014) 0.85
Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms. Appl Environ Microbiol (2016) 0.84
NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: emergence & clinical implications. Indian J Med Res (2014) 0.81
Rapid detection of New Delhi metallo-β-lactamase gene and variants coding for carbapenemases with different activities by use of a PCR-based in vitro protein expression method. J Clin Microbiol (2014) 0.77
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infect Drug Resist (2015) 0.77
The Modified Carbapenem Inactivation Method (mCIM) for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae. J Clin Microbiol (2017) 0.77
Clinical correlates of New Delhi metallo-beta lactamase isolates--a survey of published literature. Indian J Med Res (2012) 0.75
The first case of septicemia caused by imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae. Ann Lab Med (2013) 0.75
Screening for New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: Is there a role for the modified Hodge test? Pak J Med Sci (2016) 0.75
Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States Children. Open Forum Infect Dis (2016) 0.75
High Prevalence of blaNDM-1, blaVIM, qacE, and qacEΔ1 Genes and Their Association with Decreased Susceptibility to Antibiotics and Common Hospital Biocides in Clinical Isolates of Acinetobacter baumannii. Microorganisms (2017) 0.75
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 35.92
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother (2009) 16.90
Carbapenem-hydrolyzing beta-lactamases. Antimicrob Agents Chemother (1997) 7.17
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep (2010) 4.24
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect (2010) 2.10
Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis (2004) 1.71
Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory. J Clin Microbiol (2007) 1.35
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis (2011) 6.57
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol (2006) 3.34
Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol (2013) 2.75
A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A (2010) 2.41
Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis (2009) 2.24
Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol (2008) 2.13
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2010) 1.94
The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother (2012) 1.73
Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother (2010) 1.70
Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol (2011) 1.68
Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol (2013) 1.64
Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol (2002) 1.64
Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol (2009) 1.63
Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377. Pediatrics (2003) 1.57
Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol (2010) 1.57
Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J Clin Microbiol (2013) 1.56
Multi-locus variable number tandem repeat analysis for investigation of the genetic association of Clostridium difficile isolates from food, food animals and humans. Anaerobe (2011) 1.45
New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis (2013) 1.40
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics (2005) 1.39
Detection of intestinal protozoa in the clinical laboratory. J Clin Microbiol (2013) 1.32
In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis (2012) 1.28
Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.26
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr (2010) 1.24
Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J Immunol (2008) 1.24
Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol (2009) 1.24
Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins. J Virol (2005) 1.22
IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J Clin Microbiol (2011) 1.19
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol (2013) 1.16
First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin. J Clin Microbiol (2010) 1.14
Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses (2002) 1.14
Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol (2010) 1.12
Thymic function and impaired maintenance of peripheral T cell populations in children with congenital heart disease and surgical thymectomy. Pediatr Res (2004) 1.08
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem (2007) 1.07
Two-tiered universal newborn screening strategy for severe combined immunodeficiency. Mol Genet Metab (2005) 1.05
Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol (2014) 1.05
Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother (2012) 0.99
Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther (2014) 0.98
Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation (2005) 0.97
The Cpx envelope stress response both facilitates and inhibits elaboration of the enteropathogenic Escherichia coli bundle-forming pilus. Mol Microbiol (2010) 0.95
Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays. J Clin Microbiol (2005) 0.93
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol (2003) 0.93
Rapid detection of Campylobacter antigen by enzyme immunoassay leads to increased positivity rates. J Clin Microbiol (2012) 0.93
Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. J Clin Microbiol (2013) 0.91
Establishing diagnosis of Haemophilus parainfluenzae as etiology of culture-negative endocarditis using DNA sequence analysis on tissue specimen. Am J Med (2011) 0.91
Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS One (2010) 0.90
Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector. Vaccine (2009) 0.89
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline. Clin Infect Dis (2014) 0.89
Isolation and detection of Borrelia burgdorferi DNA from cerebral spinal fluid, synovial fluid, blood, urine, and ticks using the Roche MagNA Pure system and real-time PCR. Diagn Microbiol Infect Dis (2003) 0.88
Etiology associated with developing posthemispherectomy hydrocephalus after resection-disconnection procedures. J Neurosurg Pediatr (2013) 0.87
Aureobasidium pullulans var. melanigenum fungemia in a pediatric patient. Med Mycol (2010) 0.87
Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome. J Antimicrob Chemother (2013) 0.86
Aerococcus urinae and trimethoprim-sulfamethoxazole. J Clin Microbiol (2011) 0.85
Jaundice in a neonate with congenital diaphragmatic hernia. Paediatr Child Health (2009) 0.85
Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol (2013) 0.84
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. J Clin Microbiol (2013) 0.83
A real-time quantitative PCR assay for evaluating Clostridium difficile adherence to differentiated intestinal Caco-2 cells. J Med Microbiol (2010) 0.83
Timing and predictors of fever and infection after craniotomy for epilepsy in children. Pediatr Infect Dis J (2013) 0.83
Functional analysis of HIV type 1 Nef gene variants from adolescent and adult survivors of perinatal infection. AIDS Res Hum Retroviruses (2011) 0.82
Fevers and abnormal blood and cerebrospinal fluid studies after pediatric cerebral hemispherectomy: impact of etiology and age at surgery. J Neurosurg Pediatr (2013) 0.82
Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis (2011) 0.81
Target-specific capture enhances sensitivity of electrochemical detection of bacterial pathogens. J Clin Microbiol (2011) 0.81
Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes? Clin Infect Dis (2012) 0.81
Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One (2011) 0.81
N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. J Biol Chem (2012) 0.80
Molecular characterization of Staphylococcus aureus and influenza virus coinfections in patients with fatal Pneumonia. J Clin Microbiol (2013) 0.79
Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea. Am J Infect Control (2012) 0.79
HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Res Hum Retroviruses (2002) 0.79
Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr (2016) 0.79
Legionella steelei sp. nov., isolated from human respiratory specimens in California, USA, and South Australia. Int J Syst Evol Microbiol (2011) 0.78
Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. AIDS Res Hum Retroviruses (2012) 0.78
Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory. Diagn Microbiol Infect Dis (2011) 0.78
Quadrivalent human vaccine - a call to action and for additional research. Pediatr Res (2007) 0.77
Oral corticosteroids in cat-scratch disease. Clin Pediatr (Phila) (2003) 0.77
Reply to "risks of 'blind' automated identification systems in medical microbiology". J Clin Microbiol (2013) 0.77
Antibiotic resistance: how serious is the problem, and what can be done? Clin Chem (2012) 0.77
Antibiotic prescription with asthma medications: why is it so common? Pediatrics (2011) 0.77
Use of rapid diagnostic tests for diagnosis of malaria in the United States. J Clin Microbiol (2012) 0.77
Francisella philomiragia Bacteremia in a Patient with Acute Respiratory Insufficiency and Acute-on-Chronic Kidney Disease. J Clin Microbiol (2015) 0.76
Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States. Obstet Gynecol (2016) 0.76
Supranormal thymic output up to 2 decades after HIV-1 infection. AIDS (2016) 0.76
SARS: the first pandemic of the 21st century. Pediatr Res (2004) 0.76
Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant (2004) 0.76
Enfuvirtide antiretroviral therapy in HIV-1 infection. Ther Clin Risk Manag (2008) 0.76
In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1. Open Med Inform J (2010) 0.75
Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation. Transplantation (2016) 0.75
Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapy. AIDS Res Hum Retroviruses (2010) 0.75
Editorial: developmental regulation of P-glycoprotein and HIV therapy: spare the thymus but spoil the child? J Leukoc Biol (2011) 0.75